Evidence map›Paper›PMID 33978755›Full record

ArticleNucleic acids research2021

antiSMASH 6.0: improving cluster detection and comparison capabilities.

Kai Blin, Simon Shaw, Alexander M Kloosterman, Zach Charlop-Powers, Gilles P van Wezel, Marnix H Medema, Tilmann Weber

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,442 papers.

0numbers the graph read from it
0cells of the map it votes in
1,442citing papers in PubMed
176.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,442 citing papers in PubMed, 2,596 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Taxogenomic and Physiological Characterization ofInternational journal of molecular sciences · 2026
    Article
  7. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  8. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  9. Article
  10. Microorganisms · 2026
    Article
  11. Review
  12. Genomic exploration ofMicrobiology spectrum · 2026
    Article
  13. Article
  14. Article
  15. High-level prodigiosin production inSynthetic and systems biotechnology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,382 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kai BlinThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.ORCID 0000-0003-3764-6051
Simon ShawThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.
Alexander M KloostermanInstitute of Biology, Leiden University, Leiden, The Netherlands.
Zach Charlop-PowersBioinformatics, Lodo Therapeutics, New York, USA.ORCID 0000-0001-8816-4680
Gilles P van WezelInstitute of Biology, Leiden University, Leiden, The Netherlands.ORCID 0000-0003-0341-1561
Marnix H MedemaInstitute of Biology, Leiden University, Leiden, The Netherlands.ORCID 0000-0002-2191-2821
Tilmann WeberThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.ORCID 0000-0002-8260-5120
Leiden University · NLNovo Nordisk Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many microorganisms produce natural products that form the basis of antimicrobials, antivirals, and other drugs. Genome mining is routinely used to complement screening-based workflows to discover novel natural products. Since 2011, the "antibiotics and secondary metabolite analysis shell-antiSMASH" (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free-to-use web server and as a standalone tool under an OSI-approved open-source license. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in bacteria and fungi. Here, we present the updated version 6 of antiSMASH. antiSMASH 6 increases the number of supported cluster types from 58 to 71, displays the modular structure of multi-modular BGCs, adds a new BGC comparison algorithm, allows for the integration of results from other prediction tools, and more effectively detects tailoring enzymes in RiPP clusters.

Indexed as

Genome, MicrobialSoftwareBacteriaBiological ProductsBiosynthetic PathwaysFungiSecondary MetabolismBiological Products

Identifiers

PMID33978755
PMCPMC8262755
OpenAlexW3161596995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.